Citius Pharmaceuticals, Inc. CTXR

Set alert

Price alert · CTXR

All alert types
0.54 USD -0.03 -4.47%

As of Nov 3, 12:18 PM ET

Bid
0.52 × 2
Ask
0.55 × 2
0.5369 Day range 0.56
0.37 52-week range 1.54
YTD
-30.90%
1 year
-64.68%
Open
0.56
Prev close
0.562
Mkt cap
14.74M
Vol
15.80K
Avg vol
473.08K
EPS
-1.75
P/E
0.00
Div yield
0.00%
More statistics
Low
0.5369
High
0.56
Forward P/E
15.32
Beta
1.66
Short ratio
1.23
Inst. own
13.17%
Dividend
0.00
Ex-div date
Earnings
Jan 3, 2025
50-d avg
6.51
200-d avg
14.50
1y target
54.00

5D chart

Chart tools
Interval

Signals (112)
NameTimeAgo
SMA: BullishNov 2, 1:50 PM22 hours ago
MACD: Buy SignalNov 2, 1:50 PM22 hours ago
SMA: BearishNov 2, 1:45 PM22 hours ago
SMA: BullishNov 2, 1:40 PM23 hours ago
SMA: BullishNov 2, 1:40 PM23 hours ago
SMA: BearishNov 2, 1:25 PM23 hours ago
SMA: BearishNov 2, 1:25 PM23 hours ago
SMA: BullishNov 2, 1:15 PM23 hours ago
SMA: BullishNov 2, 1:15 PM23 hours ago
SMA: BearishNov 2, 1:00 PM23 hours ago
MACD: Sell SignalNov 2, 12:50 PM23 hours ago
SMA: BearishNov 2, 12:45 PM23 hours ago
SMA: BullishNov 2, 12:20 PM1 day ago
MACD: Buy SignalNov 2, 12:20 PM1 day ago
SMA: BullishNov 2, 12:10 PM1 day ago
MACD: Sell SignalNov 2, 12:10 PM1 day ago
SMA: BearishNov 2, 11:55 AM1 day ago
SMA: BearishNov 2, 11:50 AM1 day ago
SMA: BullishNov 2, 11:35 AM1 day ago
MACD: Buy SignalNov 2, 11:35 AM1 day ago

Newest 20 of 112.

Analyst view

Price target (mean) 54.00 +9957.7% upside
Target (low)
8.00
Target (mean)
54.00
Target (high)
100.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CTXR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.50-2.00 – -1.00-1.75+14.3%00.0%2
Next quarter-1.25-1.25 – -1.250.000.0%7.06M0.0%1
Current year-5.63-6.50 – -4.75-5.50-2.3%00.0%2
Next year0.125-4.50 – 4.75-5.63+102.2%39.59M0.0%2

Upgrades and downgrades

The latest rating changes

CTXR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 22, 2024D. Boral CapitalDowngradeBuyHold
Nov 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 11, 2024D. Boral CapitalMaintainedBuyBuy
Aug 19, 2024EF HuttonMaintainedBuyBuy
Aug 8, 2024EF HuttonMaintainedBuyBuy
Aug 5, 2024EF HuttonMaintainedBuyBuy
Jul 15, 2024EF HuttonInitiated—Buy
May 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 10, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 1, 2023HC Wainwright & Co.MaintainedBuyBuy
May 30, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 3, 2023HC Wainwright & Co.Reiterated—Buy
Mar 29, 2023HC Wainwright & Co.Reiterated—Buy
Jan 18, 2022HC Wainwright & Co.Maintained—Buy
Nov 30, 2021Maxim GroupInitiated—Buy
May 23, 2018HC Wainwright & Co.Initiated—Buy